Elixirgen Therapeutics has signed an option agreement with Nippon Shinyaku [...]

Cereno Scientific has reported encouraging 12-month safety and clinical observations [...]

The European Commission has granted orphan drug designation to Chiesi [...]

Grifols has launched Fesilty in the USA, making the fibrinogen [...]

FDA has granted orphan drug designation to Tris Pharma’s investigational [...]

CONNECTA Therapeutics has started a Phase 2a clinical trial of [...]

Skyhawk Therapeutics has reported encouraging 12-month results from its ongoing [...]

Intellia Therapeutics has reported positive Phase 3 results for lonvoguran [...]

DEBRA Research, a non-profit focused on Epidermolysis bullosa (EB), has [...]

Pharvaris has secured approximately $175 million through a public offering [...]